MSB 3.19% 97.0¢ mesoblast limited

CHF Accelerated Approval !, page-47

  1. 5,579 Posts.
    lightbulb Created with Sketch. 2025
    I keep thinking about the timing with THI putting out that article with guidance about patients seeking unproven stem cell therapies.

    How many CHF patients will be asking, "when can I get treated with Rexlemestrocel?"

    Will they start lobbying the FDA?

    https://pubmed.ncbi.nlm.nih.gov/35258626/

    Last edited by LearningEachDay: 20/03/22
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
97.0¢
Change
0.030(3.19%)
Mkt cap ! $1.110B
Open High Low Value Volume
94.0¢ 98.0¢ 92.0¢ $3.342M 3.477M

Buyers (Bids)

No. Vol. Price($)
4 33313 97.0¢
 

Sellers (Offers)

Price($) Vol. No.
97.5¢ 73982 2
View Market Depth
Last trade - 16.10pm 03/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.